Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
Clinical trial NCT01769508 · TERMINATED
Trial details
- NCT number
- NCT01769508
- Sponsor
- SCRI Development Innovations, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-02-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.